A Study of CM326 in Subjects With Moderate to Severe Asthma

NCT05774340 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

DRUG: CM326
OTHER: Placebo

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.